European Archives - European Medical Journal

Hideki Garren on rethinking multiple sclerosis care

Hideki Garren explores how our understanding of MS is evolving, the challenge of measuring disease progression and what the future holds.

COVID-19 Outcomes in Cystic Fibrosis Transplants

New research explores COVID-19 outcomes in cystic fibrosis transplant recipients, highlighting lung function as a potential factor linked to disease severity.

New Blood Test Detects Missed Endometriosis Cases

Scientists have developed a new blood test that accurately detects endometriosis, catching cases missed by standard imaging techniques.

HLA-B27 Status Shapes Axial Spondyloarthritis Phenotype

An MRI-based cohort study shows HLA-B27–positive axial spondyloarthritis is linked to higher inflammation and distinct clinical features, with similar treatment use across groups.

Liposomal Retinol and Niacinamide Show Enhanced Delivery and Efficacy

Liposomal retinol and niacinamide improve stability, skin penetration, and anti-aging effects, offering promise for advanced skincare formulations.

Parkinson’s Weight Loss: A Hidden Driver of Decline?

Parkinson’s weight loss is increasingly recognised as a key factor in disease progression, linked to frailty, cognitive decline and reduced quality of life.

Breastfeeding and Allergy Prevention

In this series, host Catherine Glass speaks with Debbie Palmer about the growing global challenge of childhood allergies and the powerful role of early-life nutrition in prevention.

UKHSA

Meningitis Cases Drop in Latest UK Outbreak Update

Confirmed MenB cases now stand at 29, after reaching a peak of 34 over the weekend, according to UKHSA.

Fast-Growing Lung Cancer Risk Factors Identified on CT Imaging

Solid nodules, smoking, and male sex are linked to fast-growing lung cancers on CT, highlighting patients at higher risk of rapid progression.

EU at Very Low Risk from UK Meningitis Outbreak, Says Health Authority

The European Centre for Disease Prevention and Control has reported that the general population in the EU is at very low risk of invasive meningococcal disease.